ALGN vs MEDP: Which Stock Is the Better Buy?
Align Technology, Inc. and Medpace Holdings, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — ALGN vs MEDP, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Align Technology, Inc. (ALGN) | Medpace Holdings, Inc. (MEDP) | |
|---|---|---|
| Market cap | $13.2B | $13.3B |
| Revenue (latest FY) | $4.03B | $2.53B |
| Net income (latest FY) | $410.35M | $451.12M |
| Revenue growth (5y CAGR) | 10.3% | 22.3% |
| Net margin | 10.2% | 17.8% |
| Return on equity | 10.1% | 98.3% |
| P/E ratio | 31.1 | 29.3 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
See the full ALGN vs MEDP breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open ALGN's full financials → Open MEDP's full financials →More comparisons
Frequently asked questions
Which is bigger, ALGN or MEDP?
Medpace Holdings, Inc. is larger by market capitalization — $13.3B versus $13.2B.
Which grows faster, ALGN or MEDP?
Over the last five fiscal years, Medpace Holdings, Inc. grew revenue faster — 22.3%/yr versus 10.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.